Zi-hao Qi

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.

Tumor-Infiltrating NETs Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.

Journal: Annals of surgical oncology

Published: May 29, 2018

Angiogenesis in pancreatic cancer: current research status and clinical implications.

Angiogenesis in pancreatic cancer: current research status and clinical implications.

Journal: Angiogenesis

Published: April 05, 2018

Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.

Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma.

Journal: Annals of surgical oncology

Published: March 08, 2018

The Significance of Liquid Biopsy in Pancreatic Cancer.

The Significance of Liquid Biopsy in Pancreatic Cancer.

Journal: Journal of Cancer

Published: December 27, 2017

RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.

RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.

Journal: International journal of oncology

Published: November 15, 2017

[Corrigendum] RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.

[Corrigendum] RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.

Journal: International journal of oncology

Published: November 15, 2017

Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma.

Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: October 18, 2017

Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer.

Neoadjuvant Therapy is Essential for Resectable Pancreatic Cancer.

Journal: Current medicinal chemistry

Published: October 14, 2017

The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis.

The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: A meta-analysis.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: September 08, 2017

Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.

Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.

Journal: Annals of surgical oncology

Published: May 23, 2017

Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.

Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.

Journal: Surgery

Published: May 15, 2016

Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.

Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.

Journal: Scientific reports

Published: May 14, 2016

Showing 1-12 of 13

Last Updated: 09/26/2026